Celeri Health

What Celeri Health does

Celeri Health, Inc. (operating as Celéri Health) is a privately held Delaware corporation that provides evidence infrastructure software for the pain and neuromodulation sector. The company was founded in 2018 and operates from Conshohocken, Pennsylvania, with a team of 1–10 employees. Its product portfolio spans four interlocking components built on a single regulatory-compliant data backbone: (1) the EaaS Platform, a managed evidence service for medtech and pharma sponsors covering commercial launch, label expansion, and regulatory submissions through a Commercial Insights Registry and Regulatory-Grade Evidence Cohort pathway; (2) PainIntel, a practice-level registry for interventional pain physicians offering 30+ validated PRO instruments and 8 EHR integrations; (3) PainRWD Science Cloud, a de-identified longitudinal dataset of 260,000+ patients and 2.4M records used for external benchmarking, HEOR modeling, and payer dossiers; and (4) myPainIntel, a patient-facing mobile app for PRO check-ins and visual pain tracking. The January 2025 launch of PatientFinder AI extends the platform into LLM-based patient-trial matching and advanced therapy eligibility identification.

The platform is engineered to be 21 CFR Part 11-compliant and HIPAA-governed from enrollment day one, enabling commercial and regulatory-grade evidence generation on the same patient cohort without infrastructure rebuild — a positioning the company uses to claim an 85% cost reduction and 8-week time-to-deployment versus traditional CRO study design. Celeri generates revenue through managed-service EaaS engagements with enterprise sponsors, per-provider PainIntel subscriptions at $329–$399/month, hardware sales (assessment tablets at $150/unit), and bespoke clinical research services through Celéri Research Group. Go-to-market combines enterprise field sales for medtech/pharma sponsors with a product-led self-serve motion (60-day free trial) for physician practices, supplemented by QR-code direct-to-patient enrollment that bypasses sales rep involvement. Named customers include Medtronic, PainTeq, Averitas Pharma, CornerLoc, Interaxon, Ethos, Aurora, Guam Regional Medical City, and an unnamed national biologics company.

Leadership comprises CEO Sean McCrossen, co-founders Michael Fishman, MD and Jason Pope, MD (both interventional pain physicians serving as Co-Chief Medical Officer & Co-President), and CTO/co-founder David Tannenbaum, with Cam Teems as VP of Commercial, Research & Data Operations. Funding history is not publicly disclosed beyond a nominal $0 entry attributed to Iaso Ventures in 2021; the company appears to be privately financed without reported institutional rounds and operates as an independent entity with no parent company or subsidiaries.

Name

Celeri Health

Legal name

Celéri Health, Inc.

Website

https://celerihealth.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Celeri Health provides evidence infrastructure software for pain and neuromodulation, serving medtech/pharma sponsors, interventional pain physicians, and payers with a unified platform spanning point-of-care outcomes, commercial registries, and regulatory-grade real-world evidence.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Evidence Platform

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

akta.pro secondary industries

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Patient Intake, Digital Registration & eForms (HLACAEAF), Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM), Pain Management Clinics (Interventional & Medical) (HLAFABAH)

Keywords

• Patient reported outcomes
• Real-world evidence platform
• Clinical evidence infrastructure
• Pain outcomes analytics
• Healthcare data registry

Headquarters

HQ city

Paoli

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Evidence-as-a-Service (EaaS) Subscriptions: Complete evidence infrastructure delivered as a managed service engagement for medtech and pharma sponsors. Full platform, managed operations, and regulatory-grade infrastructure included. Priced as service engagement rather than software license.
2. PainIntel Platform Subscription: Monthly subscription per billable provider for pain physician practice registry. $329/month for standard accounts, $399/month for integrated EMR/EHR accounts. Includes two initial patient tablets. Additional tablets priced at $150 each.
3. Hardware Sales: Celéri Health Assessment Tablet with protective case sold at $150/unit. Replacement tablet cases at $25 each. Hardware provided as configured patient engagement devices.
4. Research Group Services: Boutique clinical study management including study design, EDC, biostatistics, medical writing, regulatory consulting, site monitoring, and site access to 350+ pain network providers. Customizable contract structure including only required services.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Celéri Health provides a software platform that captures patient-reported outcomes (PROs) at the point of care and builds longitudinal real-world evidence datasets for interventional pain and neuromodulation. Its Evidence-as-a-Service (EaaS™) infrastructure serves medtech and pharma sponsors with commercial and regulatory-grade evidence generation, while PainIntel™ delivers practice-level registries and analytics to pain physicians. The PainRWD™ Science Cloud aggregates de-identified longitudinal data across 260,000+ patients for benchmarking, external control groups, and HEOR modeling.

Product overview

Celeri Health offers a platform-plus-modules architecture built around its Evidence-as-a-Service (EaaS™) platform, which serves as the core infrastructure connecting point-of-care outcomes, commercial registries, and regulatory-grade real-world evidence. The product portfolio comprises PainIntel™ (the point-of-care registry for pain physicians), PainRWD™ Science Cloud (the large-scale de-identified real-world data repository), and myPainIntel™ Mobile App (patient-facing engagement tool). These products share a governed data backbone and support both commercial intelligence (Commercial Insights Registry™) and regulatory-grade evidence pathways (Regulatory-Grade Evidence Cohort™) on the same patients. The platform integrates 8 EHR systems, supports CRM-based enrollment workflows, and incorporates AI capabilities including PatientFinder™ for clinical trial matching and NLP-based clinical note analysis.

Differentiator

Problem solved

Functional benefit

Brands

• EaaS™ Platform: Evidence-as-a-Service platform providing end-to-end evidence infrastructure for medtech and pharma sponsors with Commercial Insights Registry™ and Regulatory-Grade Evidence Cohort™ capabilities.
• PainIntel™
• myPainIntel™
• PainRWD™ Science Cloud
• PatientFinder™
• Celéri Explorer Research Group
• Celéri Labs

Products and services

• Celéri EaaS™ Platform (Evidence-as-a-Service) End-to-end managed evidence infrastructure platform for medtech and pharma sponsors that generates commercial intelligence and regulatory-grade real-world evidence on the same patients. Delivered as an 8-week deployment engagement with full platform, managed operations, and 21 CFR Part 11 / HIPAA-governed infrastructure included.
• PainIntel™ Practice-level registry and outcomes platform for interventional pain physicians offering 30+ validated PRO instruments, 8 EHR integrations at no cost, automated patient outreach, and a real-time Pain Command Center. Priced at $329/month standard or $399/month with EHR integration per billable provider, with 60-day free trial; CPT 96127 reimbursement eligible.
• PainRWD™ Science Cloud Large de-identified longitudinal real-world pain dataset containing PROs, procedures, diagnoses, and utilization signals. Used for external control groups, HEOR modeling, payer dossiers, and benchmarking sponsor evidence across pain therapies.
• myPainIntel™ Mobile App Patient-facing mobile app for PRO check-ins, visual pain tracking, and longitudinal outcomes monitoring, with Google Fit/Health Connect integration. Designed to improve completion rates and long-term follow-through in both practice and sponsored registry contexts.
• PatientFinder™ AI AI-applied LLM-based patient matching system for clinical trials and point-of-care advanced therapy eligibility identification, using bidirectional EHR connectivity to surface matching patients by therapy or treatment type.
• Celéri Research Group (Explorer Research Group) Boutique clinical study management service including study design, EDC, biostatistics, medical writing, regulatory consulting, site monitoring, and site access to 350+ pain network providers. Customizable contract structure with only required services selected.
• Celéri Health Assessment Tablet Clinical tablet hardware pre-loaded with Celéri software for administration of pain assessments, sold at $150 per unit with protective case. Configured as patient engagement devices for practices using the PainIntel platform.

Quantifiable outcome

• 85% cost reduction vs traditional CRO study design
• +7 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core.

• PatientFindercoreTechnology or Integration · 27 January 2025AI-applied LLM product released by Celéri for patient matching to clinical trials and point-of-care advanced therapy eligibility identification. Proprietary technology using bidirectional EHR connection to surface matching patients by therapy type.
• National Biologics Company (unnamed)coreStrategic or Co-development Partner · 1 January 2025Real-world evidence partnership to generate structured longitudinal outcomes data for regenerative tissue and biologic therapies in interventional pain and spine care. Celéri deploys EaaS platform to establish Commercial Insights Registry with pathway to Regulatory-Grade Evidence Cohort for FDA-submissible RWE.
• Guam Regional Medical CitycoreStrategic or Co-development Partner · 10 January 2024First-of-its-kind Pain Safety Net Program bringing outcomes monitoring and access infrastructure to underserved SCS patients in Pacific region. Program serves Guam, Micronesia, Northern Marianas, Palau, and Marshall Islands. Alerts providers when patient pain hits certain thresholds.
• Averitas PharmacoreStrategic or Co-development Partner · 19 December 2023Post-market observational multi-center study examining outcomes in neuropathy patients using QUTENZA high-concentration capsaicin dermal patch. Celéri Research Group provides clinical study management with Clinical Research Strategies as CRO partner.
• Clinical Research StrategiescoreImplementation/ SI/ Consulting Partner · 1 December 2023Award-winning CRO partner within Celéri Research Group providing contract research organization and executive management consultancy for clinical trials. Supports study design, biostatistics, regulatory consulting, and site monitoring services.
• GooglecoreTechnology or Integration · 24 October 2023Collaboration with Google to leverage Firebase and Google Cloud Platform services including BigQuery, Cloud Run, and Looker. Projects include EHR data examination for pain intervention quality measurement, AI algorithm testing, NLP examination of longitudinal clinical notes, and ML model development.
• Celéri LabscoreTechnology or Integration · 24 October 2023Technology innovation team within Celéri focused on research areas including EHR data examination, AI algorithm testing, NLP examination of clinical notes, and pain data ML. Collaborates with Google on Firebase and GCP services.
• CornerLoccoreTechnology or Integration · 16 August 2023Technology collaboration for pending multi-center SPARTAN Study. Celéri provides platform for patient outcomes data gathering and management, EDC, and regulatory-compliant evidence infrastructure.
• PainTeqcoreTechnology or Integration · 22 August 2022MedTech sponsor partner using Celéri EaaS platform for commercial outcomes registry. PainTeq is a spinal cord stimulation company utilizing Celéri's evidence infrastructure for real-time commercial intelligence and regulatory-grade evidence generation.
• MedtroniccoreTechnology or Integration · 22 August 2022Landmark study partnership for DTM SCS therapy measuring patient quality of life using PROMIS-29. Medtronic, a global leader in medical technology, partnered with Celéri Health to understand what 'better' means in pain care and neuromodulation through real-world outcomes measurement.
• Interaxon (Muse)coreStrategic or Co-development Partner · 22 August 2022Clinical validation partnership for Muse mEEG Biofeedback system and Transforming Pain eCourse. Celéri co-founders assessed participants using cold pressor test and validated PRO measures including PROMIS-29. Partnership enables non-opioid digital intervention validation for chronic pain management.
• CornerLoccoreTechnology or Integration · 22 August 2022Technology collaboration for SPARTAN multi-center study deploying Celéri's platform for patient outcomes data gathering and management. Celéri provides EDC, data management, and regulatory-compliant evidence infrastructure for CornerLoc device study.
• University of Wisconsin-MadisoncoreStrategic or Co-development Partner · 27 April 2022Partnership with UW-Madison Center for Health Disparities Research to integrate Neighborhood Atlas Area Deprivation Index (ADI) into clinical outcomes workflows. ADI incorporates 17 SDOH factors including income, education, employment, and housing quality to rank neighborhood disadvantage levels.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Medable: Leading eCOA/ePRO and decentralized clinical trial platform used by large pharma and MedTech sponsors to collect patient-reported outcomes and run remote studies. Direct overlap with Celeri's PainIntel PRO collection and EaaS sponsor infrastructure.
• Castor: eClinical platform combining EDC, ePRO, and eConsent for clinical research, with bidirectional EHR connectivity and AI-based patient matching. Comparable to Celeri's EDC, PRO, and PatientFinder AI capabilities across the same sponsor buyer base.
• Signant Health: Specialized eCOA/ePRO, patient engagement, and rater training provider for clinical trials across therapeutic areas. Closely comparable to Celeri's PRO data collection layer for sponsor evidence programs.
• Clinical Ink: eCOA/ePRO and digital endpoint platform serving pharma and biotech sponsors with patient-facing data capture and sensor integration. Directly comparable on PROs, eDiaries, and sponsor-managed evidence collection.

Broad incumbents

• IQVIA: Global CRO and RWE leader with E360, OCE, and Connected Health platforms that compete with Celeri's EaaS and PainRWD offerings for medtech and pharma evidence budgets, but across a much broader therapeutic portfolio.
• Veradigm: Ambulatory EHR and practice management vendor (formerly Allscripts) with embedded PRO and outcomes capabilities for physician practices. Broad incumbent competing for pain practice workflow and PRO capture budgets that Celeri's PainIntel also targets.

Emerging players

• PatientIQ: Outcomes and PRO platform focused on orthopedic and specialty surgical practices. Closely comparable to Celeri's PainIntel practice registry and patient-reported outcomes workflows, with overlap in specialty procedure-focused evidence generation.
• OutcomeMD: Patient-reported outcomes platform designed for specialty surgical practices to automate PROM collection and benchmarking. Comparable to Celeri's PainIntel for pain physician practices and PRO-driven practice benchmarking.
• Hinge Health: Digital MSK care platform combining virtual PT, wearable sensors, and PRO-based outcomes tracking. Overlaps with Celeri's PRO/measurement layer for pain conditions, though Hinge focuses on conservative care delivery rather than evidence infrastructure for sponsors.
• Deep 6 AI: AI patient-trial matching platform that uses EHR data and NLP to surface eligible patients for clinical trials. Directly comparable to Celeri's PatientFinder AI LLM-based patient eligibility identification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cel%C3%A9ri-health
• Xx.com/Celeri_Health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celeri Health